NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/04/2026
Back to search
Official data from USPTO
ALX ONCOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
03/05/2026
Trademark type
Word
Nice classes
5
Filing date
03/06/2018
Registration date
12/17/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/04/2026
Last transaction
03/05/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/08/2019
First use in commerce
05/08/2019
Drawing code
4
Owner type
03
Owner location
San Francisco, CA, US
Examiner
MARTINS, ODETTE
Current location
Historical data usage
Holders and representatives
Holders
ALX Oncology, Inc.
ALX Oncology, Inc.
Representatives
Rachelle A. Dubow, Esq. MORGAN, LEWIS & BOCKIUS LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceuticals for the treatment of cancer
Publications
History of USPTO decisions and trademark events.
30 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/04/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/04/2026
E815
TEAS SECTION 8 & 15 RECEIVED
12/01/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/17/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/09/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/08/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/24/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/24/2019
IUAF
USE AMENDMENT FILED
10/07/2019
EISU
TEAS STATEMENT OF USE RECEIVED
10/07/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/19/2019
EX1G
SOU EXTENSION 1 GRANTED
03/15/2019
EXT1
SOU EXTENSION 1 FILED
03/15/2019
EEXT
SOU TEAS EXTENSION RECEIVED
03/15/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/09/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/14/2018
PUBO
PUBLISHED FOR OPPOSITION
08/14/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/25/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/06/2018
ALIE
ASSIGNED TO LIE
07/06/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/20/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
06/19/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/19/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
06/19/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/19/2018
DOCK
ASSIGNED TO EXAMINER
06/18/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/12/2018
NWAP
NEW APPLICATION ENTERED
03/09/2018
Continuous trademark protection
Get notified about every new filing that threatens ALX ONCOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.